論文・総説 - 藤井　靖久

361. Fujii Y, Yoshida M, Chien L J, Kihara K, Kageyama Y, Yasukochi Y, Oshima H. Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium. Urol Int. 2000; 64 (3): 129-133. ( PubMed, DOI )

362. Fujii Y, Fukui I, Kihara K, Tsujii T, Kageyama Y, Oshima H. Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer. Eur Urol. 1999.10; 36 (4): 309-313. ( PubMed, DOI )

363. Fujii Y, Kageyama Y, Kawakami S, Kihara K, Oshima H.. Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res. 1999.07; 90 (7): 753-757. ( PubMed )

364. Arisawa C, Kihara K, Fujii Y, Ishizaka K, Masuda H, Oshima H. Possible misinterpretation on computed tomography of left inferior vena cava as retroperitoneal lymph node metastasis: a report of two cases. Int J Urol. 1999.04; 6 (4): 215-218. ( PubMed )

365. Matsuoka Y, Fujii Y, Akashi T, Gosehi N, Kihara K. Primitive neuroectodermal tumour of the adrenal gland. BJU Int. 1999.03; 83 (4): 515-516. ( PubMed )

366. Fujii Y, Fukui I, Kihara K, Tsujii T, Ishizaka K, Kageyama Y, Kawakami S, Oshima H.. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol. 1998.05; 33 (5): 464-468. ( PubMed )

367. Fujii Y, Kihara K, Tsujii T, Kawakami S, Nemoto T, Washizuka M, Oshima H. Chromophobe cell renal carcinoma in childhood. Int J Urol. 1998.01; 5 (1): 92-93. ( PubMed )

368. Kageyama Y, Kawakami S, Fujii Y, Kihara K, Oshima H.. Bacillus Calmette-Guérin enhances production and secretion of type IV collagenases in peripheral blood mononuclear cells. Jpn J Cancer Res. 1997.03; 88 (3): 281-288. ( PubMed )

369. Tosaka A, Fujii Y, Oka K. Evaluation of transrectal voiding ultrasonography in men with micturition difficulties without apparent organic obstruction of the lower urinary tract. Eur Urol. 1997; 32 (4): 420-424. ( PubMed )

370. Fujii Y, Higashi Y, Owada F, Okuno T, Mizuno H, Mizuno H. Magnetic resonance imaging for the diagnosis of prostate cancer metastatic to bone. Br J Urol. 1995.01; 75 (1): 54-58. ( PubMed )

371. Fujii Y, Ajima J, Oka K, Tosaka A, Takehara Y. Benign renal tumors detected among healthy adults by abdominal ultrasonography. Eur Urol. 1995; 27 (2): 124-127. ( PubMed )

372. Hirokawa M, Iwamoto T, Asakura S, Masuda M, Iwasaki A, Ikeda I, Fujii Y. Clinical study of infertile males with varicocele showing no typical radionuclide blood pooling on dynamic image of scrotal scintigraphy. Urology. 1991.06; 37 (6): 562-567. ( PubMed )

373. 田中 一, 藤井 靖久. CheckMate 274試験 泌尿器外科. 2022;

374. 田中 一, 松岡 陽, 藤井 靖久. . 専門性と多様性を両立させる! 泌尿器科外来ベストNAVI. 腎細胞癌 臨床泌尿器科. 2022;

375. 田中 一, 藤井 靖久.. 究極の集学的治療：膀胱温存療法 泌尿器外科. 2022;

376. 田中 一, 藤井 靖久. そもそも腎部分切除が正しいのか？腎摘の適応と意義 泌尿器外科. 2022;

377. 田中 一, 藤井 靖久. 膀胱がんの診断と治療 ライフライン21 がんの先進医療. 2022;

378. 中村 祐基, 藤井 靖久. 筋層非浸潤性膀胱癌(NMIBC)の再発と進展の予測 臨床泌尿器科. 2021.12; 75 (13): 933-940. ( 医中誌 )

379. 松岡　陽、藤井靖久. 前立腺がんに対する密封小線源封入療法を用いたfocal therapyの現状と展望 泌尿器外科. 2020.12;

380. 松岡　陽、藤井靖久. 前立腺生検の合併症マネージメント：リスク因子と予防と対策 Prostate Journal. 2020.07;